These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38902524)

  • 1. HbA
    Muthukumar A; Badawy L; Mangelis A; Vas P; Thomas S; Gouber A; Ayis S; Karalliedde J
    Diabetologia; 2024 Sep; 67(9):1955-1961. PubMed ID: 38902524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-linear renal function decline is frequent in patients with type 2 diabetes who progress fast to end-stage renal disease and is associated with African-Caribbean ethnicity and HbA
    Stoilov SI; Fountoulakis N; Panagiotou A; Thomas S; Karalliedde J
    J Diabetes Complications; 2021 May; 35(5):107875. PubMed ID: 33736882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African Caribbean Ethnicity Is an Independent Predictor of Significant Decline in Kidney Function in People With Type 1 Diabetes.
    Mangelis A; Fountoulakis N; Corcillo A; Collins J; Vas P; Hussain S; Hopkins D; Gnudi L; Thomas S; Ayis S; Karalliedde J
    Diabetes Care; 2022 Sep; 45(9):2095-2102. PubMed ID: 36044663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic variability and progression of chronic kidney disease in people with diabetes and comorbid kidney disease: Retrospective cohort study.
    Habte-Asres HH; Murrells T; Nitsch D; Wheeler DC; Forbes A
    Diabetes Res Clin Pract; 2022 Nov; 193():110117. PubMed ID: 36243232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid Intima-Media Thickness and Visit-to-Visit HbA1c Variability Predict Progression of Chronic Kidney Disease in Type 2 Diabetic Patients with Preserved Kidney Function.
    Takenouchi A; Tsuboi A; Kurata M; Fukuo K; Kazumi T
    J Diabetes Res; 2016; 2016():3295747. PubMed ID: 28090540
    [No Abstract]   [Full Text] [Related]  

  • 9. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
    Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
    BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore.
    Low S; Lim SC; Yeoh LY; Liu YL; Liu JJ; Fun S; Su C; Zhang X; Subramaniam T; Sum CF
    J Diabetes; 2017 Oct; 9(10):908-919. PubMed ID: 27935225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between visit-to-visit variability of HbA
    Yu ZB; Zhu Y; Li D; Wu MY; Tang ML; Wang JB; Chen K
    Diabetologia; 2020 Jan; 63(1):85-94. PubMed ID: 31485707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Visit-to-Visit Variability in Hemoglobin A
    Xu Y; Dong S; Fu EL; Sjölander A; Grams ME; Selvin E; Carrero JJ
    Am J Kidney Dis; 2023 Sep; 82(3):267-278. PubMed ID: 37182597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct association of visit-to-visit HbA1c variation with annual decline in estimated glomerular filtration rate in patients with type 2 diabetes.
    Takenouchi A; Tsuboi A; Terazawa-Watanabe M; Kurata M; Fukuo K; Kazumi T
    J Diabetes Metab Disord; 2015; 14():69. PubMed ID: 26380227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial.
    Tofte N; Lindhardt M; Adamova K; Bakker SJL; Beige J; Beulens JWJ; Birkenfeld AL; Currie G; Delles C; Dimos I; Francová L; Frimodt-Møller M; Girman P; Göke R; Havrdova T; Heerspink HJL; Kooy A; Laverman GD; Mischak H; Navis G; Nijpels G; Noutsou M; Ortiz A; Parvanova A; Persson F; Petrie JR; Ruggenenti PL; Rutters F; Rychlík I; Siwy J; Spasovski G; Speeckaert M; Trillini M; Zürbig P; von der Leyen H; Rossing P;
    Lancet Diabetes Endocrinol; 2020 Apr; 8(4):301-312. PubMed ID: 32135136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease.
    Gregorich M; Kammer M; Heinzel A; Böger C; Eckardt KU; Heerspink HL; Jung B; Mayer G; Meiselbach H; Schmid M; Schultheiss UT; Heinze G; Oberbauer R;
    JAMA Netw Open; 2023 Apr; 6(4):e231870. PubMed ID: 37017968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
    Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Cystatin C Kidney Function Measures With Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline.
    Li C; Ma Y; Yang C; Hua R; Xie W; Zhang L
    JAMA Netw Open; 2022 Sep; 5(9):e2234208. PubMed ID: 36178684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.